Eisai unites with Nichi-Iko to boost generics business

Eisai has partnered with fellow Japanese pharmaceutical company Nichi-Iko Pharmaceutical to expand and grow Nichi-Iko’s generic business.

As part of the deal, which was announced on Wednesday, March 28, Nichi-Iko will incrementally take control of Eisai’s generics subsidiary Elmed Eisai.

Nichi-Iko will gradually take control of the subsidiary, with the final tranche of shares due to be transferred by April next year.

Elmed Eisai was established in 1996 and focuses on “developing value-added generic drugs that are accessibly priced and easy for patients to administer”.

From October next year, Eisai will begin co-promotion of Nichi-Iko’s products, while Nichi-Iko will start co-promoting Elmed Eisai’s medicines.

The companies will also cooperate on Eisai’s active pharmaceutical ingredient business which is promoted primarily at Eisai’s Vizag plant in India.

Did you enjoy reading this story?  Sign up to our free daily newsletters and get stories sent like this straight to your inbox.